Search: onr:"swepub:oai:DiVA.org:hj-39678" > Common breast cance...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 28778naa a2203457 4500 | |
001 | oai:DiVA.org:hj-39678 | |
003 | SwePub | |
008 | 180601s2010 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:umu-39274 | |
009 | oai:DiVA.org:uu-140191 | |
009 | oai:lup.lub.lu.se:805abb9d-d52c-4188-9ec1-0386d4b66928 | |
009 | oai:gup.ub.gu.se/135360 | |
009 | oai:prod.swepub.kib.ki.se:121669047 | |
009 | oai:DiVA.org:liu-63965 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-396782 URI |
024 | 7 | a https://doi.org/10.1158/0008-5472.CAN-10-19072 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-392742 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1401912 URI |
024 | 7 | a https://lup.lub.lu.se/record/17517872 URI |
024 | 7 | a https://gup.ub.gu.se/publication/1353602 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1216690472 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-639652 URI |
040 | a (SwePub)hjd (SwePub)umud (SwePub)uud (SwePub)lud (SwePub)gud (SwePub)kid (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Antoniou, A. C.u Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom,University Turin, Department Genet Biol and Biochem, Turin, Italy,IRCCS, Ist Oncol Veneto, Immunol and Mol Oncol Unit, Padua, Italy4 aut |
245 | 1 0 | a Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers :b Implications for risk prediction |
264 | 1 | b American Association for Cancer Research,c 2010 |
338 | a print2 rdacarrier | |
500 | a SWE-BRCA SWE-BRCA collaborators: Per Karlsson, Margareta Nordling, Annika Bergman, and Zakaria Einbeigi, Gothenburg, Sahlgrenska University Hospital; Sigrun Liedgren, Linkoping University Hospital; Niklas Loman, Ha kan Olsson, Ulf Kristoffersson, Helena Jernstr€om, Katja Harbst, and Karin Henriksson, Lund University Hospital; Brita Arver, Anna von Wachenfeldt, Annelie Liljegren, and Gisela Barbany-Bustinza, Stockholm, Karolinska University Hospital; Henrik Gronberg, Eva-Lena Stattin, and Monica Emanuelsson, Umea University Hos- € pital; Hans Ehrencrona, Richard Rosenquist Brandell, and Niklas Dahl, Uppsala University Hospital | |
500 | a SWE-BRCA collaborators: Hans Ehrencrona, Richard Rosenquist Brandell and Niklas Dahl, Institutionen för genetik och patologi, Department of Genetics and Pathology, Uppsala University Hospital | |
520 | a The known breast cancer susceptibility polymorphisms in FGFR2, TNRC9/TOX3, MAP3K1, LSP1, and 2q35 confer increased risks of breast cancer for BRCA1 or BRCA2 mutation carriers. We evaluated the associations of 3 additional single nucleotide polymorphisms (SNPs), rs4973768 in SLC4A7/NEK10, rs6504950 in STXBP4/COX11, and rs10941679 at 5p12, and reanalyzed the previous associations using additional carriers in a sample of 12,525 BRCA1 and 7,409 BRCA2 carriers. Additionally, we investigated potential interactions between SNPs and assessed the implications for risk prediction. The minor alleles of rs4973768 and rs10941679 were associated with increased breast cancer risk for BRCA2 carriers (per-allele HR = 1.10, 95% CI: 1.03-1.18, P = 0.006 and HR = 1.09, 95% CI: 1.01-1.19, P = 0.03, respectively). Neither SNP was associated with breast cancer risk for BRCA1 carriers, and rs6504950 was not associated with breast cancer for either BRCA1 or BRCA2 carriers. Of the 9 polymorphisms investigated, 7 were associated with breast cancer for BRCA2 carriers (FGFR2, TOX3, MAP3K1, LSP1, 2q35, SLC4A7, 5p12, P = 7 × 10-11 - 0.03), but only TOX3 and 2q35 were associated with the risk for BRCA1 carriers (P = 0.0049, 0.03, respectively). All risk-associated polymorphisms appear to interact multiplicatively on breast cancer risk for mutation carriers. Based on the joint genotype distribution of the 7 risk-associated SNPs in BRCA2 mutation carriers, the 5% of BRCA2 carriers at highest risk (i.e., between 95th and 100th percentiles) were predicted to have a probability between 80% and 96% of developing breast cancer by age 80, compared with 42% to 50% for the 5% of carriers at lowest risk. Our findings indicated that these risk differences might be sufficient to influence the clinical management of mutation carriers. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a BRCA1 protein | |
653 | a BRCA2 protein | |
653 | a adult | |
653 | a aged | |
653 | a article | |
653 | a attributable risk | |
653 | a breast cancer | |
653 | a cancer risk | |
653 | a cancer susceptibility | |
653 | a clinical evaluation | |
653 | a controlled study | |
653 | a female | |
653 | a follow up | |
653 | a gene frequency | |
653 | a gene mutation | |
653 | a genotype | |
653 | a heterozygote | |
653 | a human | |
653 | a major clinical study | |
653 | a priority journal | |
653 | a probability | |
653 | a risk assessment | |
653 | a single nucleotide polymorphism | |
653 | a tumor suppressor gene | |
653 | a Aged | |
653 | a 80 and over | |
653 | a Alleles | |
653 | a Breast Neoplasms | |
653 | a Genetic Predisposition to Disease | |
653 | a Humans | |
653 | a Middle Aged | |
653 | a Mutation | |
653 | a Polymorphism | |
653 | a Single Nucleotide | |
653 | a Receptors | |
653 | a Progesterone | |
653 | a Risk Factors | |
653 | a Sodium-Bicarbonate Symporters | |
653 | a Survival Analysis | |
653 | a Vesicular Transport Proteins | |
653 | a MEDICINE | |
653 | a Adult | |
653 | a Aged | |
653 | a Aged, 80 and over | |
653 | a Alleles | |
653 | a BRCA1 Protein | |
653 | a BRCA2 Protein | |
653 | a Breast Neoplasms | |
653 | a Female | |
653 | a Genetic Predisposition to Disease | |
653 | a Genotype | |
653 | a Heterozygote | |
653 | a Humans | |
653 | a Middle Aged | |
653 | a Mutation | |
653 | a Polymorphism, Single Nucleotide | |
653 | a Receptors, Progesterone | |
653 | a Risk Assessment | |
653 | a Risk Factors | |
653 | a Sodium-Bicarbonate Symporters | |
653 | a Survival Analysis | |
653 | a Vesicular Transport Proteins | |
700 | 1 | a Beesley, J.u Queensland Institute of Medical Research, Brisbane, Australia4 aut |
700 | 1 | a McGuffog, L.u University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England,Mayo Clin, Department Med Genet, Rochester, MN USA4 aut |
700 | 1 | a Sinilnikova, O. M.u Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon/Centre Léon Bérard, Lyon, France,IRCCS, Ist Oncol Veneto, Immunol and Mol Oncol Unit, Padua, Italy4 aut |
700 | 1 | a Healey, S.u Queensland Institute Med Research, Brisbane, Qld, Australia4 aut |
700 | 1 | a Neuhausen, S. L.u Beckman Research Institute City Hope, Department Populat Science, Duarte, CA USA,Aalborg Hospital, Department Clin Genet, Aalborg, Denmark,Roswell Pk Canc Institute, Department Canc Prevent and Control, Buffalo, NY 14263 USA4 aut |
700 | 1 | a Ding, Y. C.u Beckman Research Institute City Hope, Department Populat Science, Duarte, CA USA,Dana Farber Canc Institute, Boston, MA 02115 USA4 aut |
700 | 1 | a Rebbeck, T. R.u University Penn, Sch Med, Abramson Canc Centre, Philadelphia, PA 19104 USA4 aut |
700 | 1 | a Weitzel, J. N.u City Hope Natl Med Centre, Duarte, CA 91010 USA4 aut |
700 | 1 | a Lynch, H. T.u Creighton University, Omaha, NE 68178 USA,Pomeranian Med University, Int Hereditary Canc Centre, Department Genet and Pathol, Szczecin, Poland,Queensland Institute Med Research, Brisbane, Qld, Australia4 aut |
700 | 1 | a Isaacs, C.u Mayo Clin, Coll Med, Department Lab Med and Pathol, Rochester, MN USA4 aut |
700 | 1 | a Ganz, P. A.u University Calif Los Angeles, Jonsson Comprehens Canc Centre, Los Angeles, CA 90024 USA,Fdn IRCCS Ist Nazl Tumori INT, Unit Genet Susceptibil Canc, Department Expt Oncol and Mol Med, Milan, Italy4 aut |
700 | 1 | a Tomlinson, G.u University Texas Hlth Science Centre San Antonio, San Antonio, TX 78229 USA4 aut |
700 | 1 | a Olopade, O. I.u University Chicago, Med Centre, Chicago, IL 60637 USA4 aut |
700 | 1 | a Couch, F. J.u Mayo Clin, Department Lab Med and Pathol, Rochester, MN USA4 aut |
700 | 1 | a Wang, X.u Mayo Clin, Department Lab Med and Pathol, Rochester, MN USA4 aut |
700 | 1 | a Nordling, Margareta,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för medicinsk genetik och klinisk genetik,Institute of Biomedicine, Department of Medical and Clinical Genetics4 aut0 (Swepub:gu)xnmarx |
700 | 1 | a Pankratz, V. S.u Mayo Clin, Department Hlth Science Research, Rochester, MN USA4 aut |
700 | 1 | a Radice, P.u Fdn IRCCS Ist Nazl Tumori INT, Unit Genet Susceptibil Canc, Department Expt Oncol and Mol Med, Milan, Italy4 aut |
700 | 1 | a Manoukian, S.u Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Department Prevent and Predict Med, Milan, Italy4 aut |
700 | 1 | a Peissel, B.u Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Department Prevent and Predict Med, Milan, Italy4 aut |
700 | 1 | a Zaffaroni, D.u Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Department Prevent and Predict Med, Milan, Italy4 aut |
700 | 1 | a Stenmark-Askmalm, Marieu Östergötlands Läns Landsting,Linköpings universitet,Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine,Onkologi,Hälsouniversitetet,Klinisk patologi och klinisk genetik4 aut0 (Swepub:liu)marst93 |
700 | 1 | a Viel, A.u IRCCS, CRO, Div Expt Oncol 1, Aviano, PN, Italy4 aut |
700 | 1 | a Allavena, A.u Karolinska Institutet,University Hospital, Department Pathol, Reykjavik, Iceland4 aut |
700 | 1 | a Dall'Olio, V.4 aut |
700 | 1 | a Peterlongo, P.4 aut |
700 | 1 | a Szabo, C. I.4 aut |
700 | 1 | a Zikan, M.u Charles University Prague, Fac Med 1, Department Biochem and Expt Oncol, Prague, Czech Republic4 aut |
700 | 1 | a Claes, K.u Ghent University Hospital, Centre Med Genet, B-9000 Ghent, Belgium4 aut |
700 | 1 | a Poppe, B.u Ghent University Hospital, Centre Med Genet, B-9000 Ghent, Belgium4 aut |
700 | 1 | a Foretova, L.u Masaryk Mem Canc Institute, Department Canc Epidemiol and Genet, Brno, Czech Republic4 aut |
700 | 1 | a Mai, P. L.u US Natl Canc Institute, Clin Genet Branch, Rockville, MD USA4 aut |
700 | 1 | a Greene, M. H.u US Natl Canc Institute, Clin Genet Branch, Rockville, MD USA4 aut |
700 | 1 | a Rennert, G.u Technion Israel Institute Technology, Carmel Med Centre, Haifa, Israel4 aut |
700 | 1 | a Lejbkowicz, F.u Technion Israel Institute Technology, Carmel Med Centre, Haifa, Israel4 aut |
700 | 1 | a Glendon, G.u OCGN, Toronto, ON, Canada4 aut |
700 | 1 | a Ozcelik, H.u Mt Sinai Hospital, Fred A Litwin Centre Canc Genet, Samuel Lunenfeld Research Institute, New York, NY 10029 USA,University Copenhagen, Rigshosp, Department Clin Biochem, DK-2100 Copenhagen, Denmark4 aut |
700 | 1 | a Andrulis, I. L.u OCGN, Toronto, ON, Canada4 aut |
700 | 1 | a Thomassen, M.u Odense University Hospital, Department Clin Genet, DK-5000 Odense, Denmark4 aut |
700 | 1 | a Gerdes, A. -Mu Rigshosp, Department Clin Genet, Odense, Denmark,Dana Farber Canc Institute, Boston, MA 02115 USA,Tech University Munich, Klinikum Rechts Isar, Department Obstet and Gynaecol, Div Tumor Genet, D-8000 Munich, Germany4 aut |
700 | 1 | a Sunde, L.4 aut |
700 | 1 | a Cruger, D.u Vejle Hospital, Department Clin Genet, Velje, Denmark4 aut |
700 | 1 | a Jensen, U. B.u Aarhus University Hospital, Department Clin Genet, DK-8000 Aarhus, Denmark4 aut |
700 | 1 | a Caligo, M.u University Pisa, Div Surg Mol and Ultrastruct Pathol, Department Oncol, Pisa, Italy4 aut |
700 | 1 | a Friedman, E.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel,University Chicago, Med Centre, Chicago, IL 60637 USA4 aut |
700 | 1 | a Kaufman, B.u Sheba Med Centre, Institute Oncol, Tel Hashomer, Israel4 aut |
700 | 1 | a Laitman, Y.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel4 aut |
700 | 1 | a Milgrom, R.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel4 aut |
700 | 1 | a Dubrovsky, M.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel4 aut |
700 | 1 | a Cohen, S.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel4 aut |
700 | 1 | a Borg, A.u Lund University, Department Oncol, Lund, Sweden,Queensland Institute Med Research, Brisbane, Qld, Australia4 aut |
700 | 1 | a Jernström, Helenau Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University, Department Oncol, Lund, Sweden4 aut0 (Swepub:lu)onk-hje |
700 | 1 | a Lindblom, A.u Karolinska Institute, Department Mol Med and Surg, Stockholm, Sweden4 aut |
700 | 1 | a Rantala, J.u Karolinska Institutet,Karolinska Institute, Department Mol Med and Surg, Stockholm, Sweden4 aut |
700 | 1 | a Stenmark-Askmalm, M.4 aut |
700 | 1 | a Melin, Beatriceu Umeå universitet,Onkologi,Umea University, Department Radiat Science, Umea, Sweden4 aut0 (Swepub:umu)bema0010 |
700 | 1 | a Nathanson, K.u University Penn, Philadelphia, PA 19104 USA4 aut |
700 | 1 | a Domchek, S.u University Penn, Philadelphia, PA 19104 USA4 aut |
700 | 1 | a Jakubowska, A.u Pomeranian Med University, Int Hereditary Canc Centre, Department Genet and Pathol, Szczecin, Poland,Leiden University, Med Centre, Department Clin Genet, Leiden, Netherlands4 aut |
700 | 1 | a Lubinski, J.u Pomeranian Med University, Int Hereditary Canc Centre, Department Genet and Pathol, Szczecin, Poland,University Melbourne, Melbourne, Vic, Australia4 aut |
700 | 1 | a Huzarski, T.4 aut |
700 | 1 | a Osorio, A.u Spanish Natl Canc Research Centre, Human Genet Grp, Human Canc Genet Programme, Madrid, Spain4 aut |
700 | 1 | a Lasa, A.u Hospital Santa Creu and Sant Pau, Genet Serv, Barcelona, Spain4 aut |
700 | 1 | a Durán, M.u University Valladolid, Institute Biol and Mol Genet, IBGM UVA, Valladolid, Spain4 aut |
700 | 1 | a Tejada, M. -Iu Cruces Hospital Barakaldo, Mol Genet Lab, Department Biochem, Bizkaia, Spain4 aut |
700 | 1 | a Godino, J.u University Lozano Blesa, Hospital Clin, Oncol Serv, Zaragoza, Spain4 aut |
700 | 1 | a Benitez, J.u Spanish Natl Canc Research Centre, Human Canc Genet Programme, Genotyping Unit, Madrid, Spain4 aut |
700 | 1 | a Hamann, U.u Deutsch Krebsforschungszentrum, Mol Genet Breast Canc, D-6900 Heidelberg, Germany4 aut |
700 | 1 | a Kriege, M.u Daniel Denhoed Canc Centre, Erasmus MC, Department Med Oncol, Family Canc Clin, Rotterdam, Netherlands4 aut |
700 | 1 | a Hoogerbrugge, N.u Radboud University Nijmegen, Nijmegen Med Centre, Hereditary Canc Clin, NL-6525 ED Nijmegen, Netherlands4 aut |
700 | 1 | a Van Der Luijt, R. B.u University Med Centre Utrecht, Department Med Genet, Utrecht, Netherlands4 aut |
700 | 1 | a Van Asperen, C. J.u Sheffield Childrens Hospital, Sheffield Clin Genet Serv, Sheffield, S Yorkshire, England4 aut |
700 | 1 | a Devilee, P.u Leiden University, Department Human Genet, Med Centre, Department Pathol, NL-2300 RA Leiden, Netherlands4 aut |
700 | 1 | a Meijers-Heijboer, E. J.u Vrije University Amsterdam Med Centre, Department Clin Genet, Amsterdam, Netherlands,Canc Prevent Institute Calif, Fremont, CA USA4 aut |
700 | 1 | a Blok, M. J.u University Med Centre, Department Genet and Cell Biol, Maastricht, Netherlands4 aut |
700 | 1 | a Aalfs, C. M.u University Amsterdam, Acad Med Centre, Department Clin Genet, NL-1105 AZ Amsterdam, Netherlands,University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England4 aut |
700 | 1 | a Hogervorst, F.u Netherlands Canc Institute, Family Canc Clin, Amsterdam, Netherlands4 aut |
700 | 1 | a Rookus, M.u Netherlands Canc Institute, Department Epidemiol, Amsterdam, Netherlands4 aut |
700 | 1 | a Cook, M.4 aut |
700 | 1 | a Oliver, C.u University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England4 aut |
700 | 1 | a Frost, D.u University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England4 aut |
700 | 1 | a Conroy, D.u University Cambridge, Department Oncol, Cambridge, England4 aut |
700 | 1 | a Evans, D. G.u Cent Manchester University Hospital NHS Fdn Trust, Manchester Acad Hlth Science Centre, Manchester, Lancs, England,University Utah, Department Dermatol, Salt Lake City, UT USA,Hannover Med Sch, Institute Cell and Mol Pathol, D-3000 Hannover, Germany4 aut |
700 | 1 | a Lalloo, F.u Cent Manchester University Hospital NHS Fdn Trust, Manchester Acad Hlth Science Centre, Manchester, Lancs, England4 aut |
700 | 1 | a Pichert, G.u Guys and St Thomas NHS Fdn Trust, London, England4 aut |
700 | 1 | a Davidson, R.u Ferguson Smith Centre Clin Genet, Glasgow, Lanark, Scotland4 aut |
700 | 1 | a Cole, T.u Birmingham Womens Hospital Healthcare NHS Trust, W Midlands Reg Genet Serv, Birmingham, W Midlands, England4 aut |
700 | 1 | a Cook, J.4 aut |
700 | 1 | a Paterson, J.u Addenbrookes Hospital, Department Clin Genet, E Anglian Reg Genet Serv, Cambridge, England4 aut |
700 | 1 | a Hodgson, S.u University London, Department Clin Genet, St Georges Hospital, London, England4 aut |
700 | 1 | a Morrison, P. J.u Belfast City Hospital, Northern Ireland Reg Genet Centre, Belfast BT9 7AD, Antrim, North Ireland4 aut |
700 | 1 | a Porteous, M. E.u Western Gen Hospital, SE Scotland Reg Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland4 aut |
700 | 1 | a Walker, L.u Churchill Hospital, Oxford Reg Genet Serv, Oxford OX3 7LJ, England4 aut |
700 | 1 | a Kennedy, M. J.u St James Hospital, Canc Genet Program, Hope Directorate, Dublin, Ireland4 aut |
700 | 1 | a Dorkins, H.u Kennedy Galton Centre, NW Thames Reg Genet Serv, Harrow, Middx, England4 aut |
700 | 1 | a Peock, S.u University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England4 aut |
700 | 1 | a Godwin, A. K.u Fox Chase Canc Centre, Department Med Oncol, Womens Canc Program, Philadelphia, PA 19111 USA,Tech University Dresden, Department Obstet and Gynaecol, University Hospital Carl Gustav Carus, Dresden, Germany,University Helsinki, Cent Hospital, Department Clin Genet, Helsinki, Finland4 aut |
700 | 1 | a Stoppa-Lyonnet, D.u University Paris 05, INSERM, U509, Serv Genet Oncol,Institute Curie, Paris, France4 aut |
700 | 1 | a De Pauw, A.u University Paris 05, INSERM, U509, Serv Genet Oncol,Institute Curie, Paris, France4 aut |
700 | 1 | a Mazoyer, S.u University Lyon 1, CNRS, Centre Leon Berard, Equipe Labellisee LIGUE 2008,UMR5201, F-69365 Lyon, France4 aut |
700 | 1 | a Bonadona, V.u University Lyon 1, CNRS, UMR5558, F-69365 Lyon, France4 aut |
700 | 1 | a Lasset, C.u University Lyon 1, CNRS, UMR5558, F-69365 Lyon, France4 aut |
700 | 1 | a Dreyfus, H.u CHU Grenoble, Department Genet, F-38043 Grenoble, France4 aut |
700 | 1 | a Leroux, D.u CHU Grenoble, Department Genet, F-38043 Grenoble, France4 aut |
700 | 1 | a Hardouin, A.u Centre Francois Baclesse, F-14021 Caen, France4 aut |
700 | 1 | a Berthet, P.u Centre Francois Baclesse, F-14021 Caen, France4 aut |
700 | 1 | a Faivre, L.u Centre Hospital University Dijon, Centre Genet, Dijon, France4 aut |
700 | 1 | a Loustalot, C.u Centre Lutte Canc Georges Francois Leclerc, Dijon, France4 aut |
700 | 1 | a Noguchi, T.u INSERM, Institute Paoli Calmettes, UMR599, Department Oncol Genet, F-13258 Marseille, France4 aut |
700 | 1 | a Sobol, H.u INSERM, Institute Paoli Calmettes, UMR599, Department Oncol Genet, F-13258 Marseille, France4 aut |
700 | 1 | a Rouleau, E.u Centre Rene Huguenin, INSERM, U735, St Cloud, France4 aut |
700 | 1 | a Nogues, C.4 aut |
700 | 1 | a Frénay, M.u Centre Antoine Lacassagne, F-06054 Nice, France4 aut |
700 | 1 | a Vénat-Bouvet, L.u Centre Hospital University Limoges, Department Oncol, Limoges, France4 aut |
700 | 1 | a Hopper, J. L.u University Copenhagen, Rigshosp, Department Clin Biochem, DK-2100 Copenhagen, Denmark4 aut |
700 | 1 | a Daly, M. B.u IEO, Div Canc Prevent and Genet, Milan, Italy,Fox Chase Canc Centre, Department Med Oncol, Womens Canc Program, Philadelphia, PA 19111 USA4 aut |
700 | 1 | a Terry, M. B.u Columbia University, New York, NY USA4 aut |
700 | 1 | a John, E. M.4 aut |
700 | 1 | a Buys, S. S.u University Utah, Hlth Science Centre, Huntsman Canc Institute, Salt Lake City, UT USA4 aut |
700 | 1 | a Yassin, Y.u Cedars Sinai Med Centre, Womens Canc Research Institute, Samuel Oschin Comprehens Canc Institute, Los Angeles, CA 90048 USA4 aut |
700 | 1 | a Miron, A.4 aut |
700 | 1 | a Goldgar, D.4 aut |
700 | 1 | a Singer, C. F.u Med University Vienna, Department Obstet and Gynecol, Vienna, Austria4 aut |
700 | 1 | a Dressler, A. C.u Med University Vienna, Department Obstet and Gynecol, Vienna, Austria4 aut |
700 | 1 | a Gschwantler-Kaulich, D.u Med University Vienna, Department Obstet and Gynecol, Vienna, Austria4 aut |
700 | 1 | a Pfeiler, G.u Med University Vienna, Department Obstet and Gynecol, Vienna, Austria4 aut |
700 | 1 | a Hansen, T. V. O.4 aut |
700 | 1 | a Jnson, L.4 aut |
700 | 1 | a Bergman, Annikau Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för medicinsk genetik och klinisk genetik,Institute of Biomedicine, Department of Medical and Clinical Genetics4 aut0 (Swepub:gu)xbannj |
700 | 1 | a Kirchhoff, T.u Mem Sloan Kettering Canc Centre, Department Med, Clin Genet Serv, New York, NY 10021 USA4 aut |
700 | 1 | a Offit, K.u Mem Sloan Kettering Canc Centre, Department Med, Clin Genet Serv, New York, NY 10021 USA4 aut |
700 | 1 | a Devlin, V.u Mem Sloan Kettering Canc Centre, Department Med, Clin Genet Serv, New York, NY 10021 USA4 aut |
700 | 1 | a Dutra-Clarke, A.u Mem Sloan Kettering Canc Centre, Department Med, Clin Genet Serv, New York, NY 10021 USA4 aut |
700 | 1 | a Piedmonte, M.u Roswell Pk Canc Institute, GOG Stat and Data Centre, Buffalo, NY 14263 USA4 aut |
700 | 1 | a Rodriguez, G. C.u NorthShore University Hlth Syst, Evanston NW Healthcare, Evanston, IL USA4 aut |
700 | 1 | a Wakeley, K.u Tufts University, New England Med Centre, Boston, MA 02111 USA4 aut |
700 | 1 | a Boggess, J. F.u University N Carolina, Chapel Hill, NC USA4 aut |
700 | 1 | a Basil, J.u St Elizabeth Hospital, Edgewood, KY USA4 aut |
700 | 1 | a Schwartz, P. E.u Yale University, Sch Med, New Haven, CT USA4 aut |
700 | 1 | a Blank, S. V.u NYU, Sch Med, New York, NY USA4 aut |
700 | 1 | a Toland, A. E.u Ohio State University, Centre Comprehens Canc, Department Internal Med and Mol Virol, Div Human Canc Genet, Columbus, OH 43210 USA4 aut |
700 | 1 | a Montagna, M.4 aut |
700 | 1 | a Casella, C.4 aut |
700 | 1 | a Imyanitov, E.u NN Petrov Institute Oncol, St Petersburg, Russia4 aut |
700 | 1 | a Tihomirova, L.u Latvian Biomed Research and Study Centre, Riga, Latvia4 aut |
700 | 1 | a Blanco, I.u Catalan Institute Oncol IDIBELL, Hereditary Canc Program, Barcelona, Spain4 aut |
700 | 1 | a Lazaro, C.u Catalan Institute Oncol IDIBELL, Hereditary Canc Program, Barcelona, Spain4 aut |
700 | 1 | a Ramus, S. J.u University London Imperial Coll Science Technology and Med, Gynaecol Oncol Unit, UCL EGA Institute Womens Hlth, London, England,Centre Hospital University Quebec, Canada Research Chair Oncogenet, Canc Genom Lab, Quebec City, PQ, Canada4 aut |
700 | 1 | a Sucheston, L.4 aut |
700 | 1 | a Karlan, B. Y.4 aut |
700 | 1 | a Gross, J.u Cedars Sinai Med Centre, Womens Canc Research Institute, Samuel Oschin Comprehens Canc Institute, Los Angeles, CA 90048 USA4 aut |
700 | 1 | a Schmutzler, R.u University Cologne, Centre Familial Breast and Ovarian Canc, Department Obstet and Gynaecol, Cologne, Germany4 aut |
700 | 1 | a Wappenschmidt, B.u University Cologne, Centre Familial Breast and Ovarian Canc, Department Obstet and Gynaecol, Cologne, Germany4 aut |
700 | 1 | a Engel, C.u University Leipzig, Institute Med Informat Stat and Epidemiol, Leipzig, Germany4 aut |
700 | 1 | a Meindl, A.4 aut |
700 | 1 | a Lochmann, M.u Tech University Munich, Klinikum Rechts Isar, Department Obstet and Gynaecol, Div Tumor Genet, D-8000 Munich, Germany4 aut |
700 | 1 | a Arnold, N.u University Kiel, Department Obstet and Gynaecol, University Hospital Schleswig Holstein, Kiel, Germany4 aut |
700 | 1 | a Heidemann, S.u University Kiel, Institute Human Genet, University Hospital Schleswig Holstein, Kiel, Germany4 aut |
700 | 1 | a Varon-Mateeva, R.u Campus Virchow Klinikum, Charite Berlin, Institute Human Genet, Berlin, Germany4 aut |
700 | 1 | a Niederacher, D.u University Dusseldorf, Department Obstet and Gynaecol, Div Mol Genet, University Hospital Dusseldorf, Dusseldorf, Germany4 aut |
700 | 1 | a Sutter, C.u University Heidelberg, Institute Human Genet, Div Mol Diagnost, Heidelberg, Germany4 aut |
700 | 1 | a Deissler, H.u University Hospital Ulm, Department Obstet and Gynaecol, Ulm, Germany4 aut |
700 | 1 | a Gadzicki, D.4 aut |
700 | 1 | a Preisler-Adams, S.u University Hospital Muenster, Institute Human Genet, Munster, Germany4 aut |
700 | 1 | a Kast, K.4 aut |
700 | 1 | a Schönbuchner, I.u University Wurzburg, Institute Human Genet, Div Med Genet, Wurzburg, Germany4 aut |
700 | 1 | a Caldes, T.u Hospital Clin San Carlos, Mol Oncol Lab, Madrid, Spain4 aut |
700 | 1 | a De La Hoya, M.u Hospital Clin San Carlos, Mol Oncol Lab, Madrid, Spain4 aut |
700 | 1 | a Aittomäki, K.4 aut |
700 | 1 | a Nevanlinna, H.u University Helsinki, Cent Hospital, Department Obstet and Gynecol, FIN-00290 Helsinki, Finland4 aut |
700 | 1 | a Simard, J.4 aut |
700 | 1 | a Spurdle, A. B.4 aut |
700 | 1 | a Holland, H.4 aut |
700 | 1 | a Chen, X.u Queensland Institute Med Research, Brisbane, Qld, Australia4 aut |
700 | 1 | a Platte, R.u Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom4 aut |
700 | 1 | a Chenevix-Trench, G.u Queensland Institute of Medical Research, Brisbane, Australia4 aut |
700 | 1 | a Easton, D. F.4 aut |
700 | 1 | a Bergman, Annikau Sahlgrenska University Hospital, Gothenburg, Sweden4 ctb0 (Swepub:hj)berann |
700 | 1 | a Einbeigi, Zakaria,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology4 aut0 (Swepub:gu)xeinza |
700 | 1 | a Karlsson, Per,d 1963u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology4 aut0 (Swepub:gu)xkperd |
700 | 1 | a DallOlio, Valentinau Cogentech, Consortium Genom Technology, Milan, Italy4 aut |
710 | 2 | a Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdomb University Turin, Department Genet Biol and Biochem, Turin, Italy4 org |
710 | 2 | a Ontario Cancer Genetics Network |
773 | 0 | t Cancer Researchd : American Association for Cancer Researchg 70:23, s. 9742-9754q 70:23<9742-9754x 0008-5472x 1538-7445 |
856 | 4 | u http://dx.doi.org/10.1158/0008-5472.CAN-10-1907y FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-39678 |
856 | 4 8 | u https://doi.org/10.1158/0008-5472.CAN-10-1907 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-39274 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-140191 |
856 | 4 8 | u https://lup.lub.lu.se/record/1751787 |
856 | 4 8 | u https://gup.ub.gu.se/publication/135360 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:121669047 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-63965 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Copy and save the link in order to return to this view